GlobeNewswire
-
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
12/08/2026 -
Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
12/08/2026 -
Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones
12/08/2026 -
Hyperion DeFi Reports 2Q 2026 Financial Results with Another Record Quarterly Net Income and Strong Operating Momentum
12/08/2026 -
Earth Science Tech, Inc. (ETST) Expands National Footprint with Strategic Acquisition of California Compounding Pharmacy, Meduvo LLC
12/08/2026 -
Rampart retire son recours contre la décision d’invalidation de l’USPTO
12/08/2026 -
Dr. Wallace Brucker Offers Galleri Multi-Cancer Early Detection Testing in Las Vegas as Part of Proactive Longevity Care
12/08/2026 -
Interra Health Named on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2026 -
New review prioritizes maternal mental health during pregnancy
12/08/2026 -
Robotic Technology at Medicana: CyberKnife Tracks Tumors in Real Time and Adjusts Radiation as Patients Breathe
12/08/2026 -
Regenix Labs Announces Educational Guide on Cortisol, Stress Management, and Healthy Adrenal Function
12/08/2026 -
Applied Biologics Launches National Health System Partnership Initiative
12/08/2026 -
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
12/08/2026 -
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
12/08/2026 -
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
12/08/2026 -
Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
12/08/2026 -
Marie-Hélène Laramée, présidente-directrice générale de la Fondation du CUSM, nommée au conseil d’administration de l’Association canadienne pour l’équité en santé des femmes
12/08/2026 -
MUHC Foundation President and CEO Marie-Hélène Laramée appointed to Women’s Health Collective Canada Board of Directors
12/08/2026 -
Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026
12/08/2026
Pages